- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06196333
Evaluation of Corneal Endothelium by Specular Microscope in Elderly Diabetic Patients
December 25, 2023 updated by: Abanoub Hennis Mahrous, Assiut University
A low endothelial count with endothelial pump dysfunction can contribute to corneal stromal hydration and loss of vision that can only be reversed by corneal transplantation,so this research proposed to detect any corneal endothelial changes related to DM , its duration and control of diabetes.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Detailed Description
- To establish any correlation between endothelial changes , and the duration of diabetes, hemoglobin A1c (HbA1c) by using specular microscope to do morphological examination of corneal endothelial cells, makes the measurement of mean cell density (MCD), measurement of coefficient of variation (CV) in the cell size as well as hexagonal appearance of the cell.
These parameters provide the functional status index of the corneal endothelial layer .
Study Type
Observational
Enrollment (Estimated)
100
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Not gender based from 40 years to 80 years diabetic patients
Description
Inclusion Criteria:
- - Diabetic patient type 2
- Elderly patients above 40 years old
Exclusion Criteria:
- - Patients with any of the following conditions have been omitted from the study included a past medical history of ocular trauma, corneal or intraocular inflammation, the use of systemic drugs that could affect endothelial cells, evidence of endothelial disease during a slit-lamp examination, previous ocular surgery (including cataract surgery), increased intraocular pressure, corneal opacity, or retinal photocoagulation procedures.
- non of the inclusion criteria patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Diabetes
Diabetes patients above 40 years
|
using specular microscope to do morphological examination of corneal endothelial cells
|
Controls
Healthy controlled human beings have no medical histories
|
using specular microscope to do morphological examination of corneal endothelial cells
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Endothelial count
Time Frame: 15 months
|
Corneal endothelial cell count, coefficient of variation, percentage of hexagonal cells and central corneal thickness will be evaluated and correlated to known normal values in the same healthy individual age group
|
15 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlated change
Time Frame: 15 months
|
Correlated change of corneal endotheliam to duration and control of DM
|
15 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 5, 2024
Primary Completion (Estimated)
November 5, 2024
Study Completion (Estimated)
May 5, 2025
Study Registration Dates
First Submitted
December 25, 2023
First Submitted That Met QC Criteria
December 25, 2023
First Posted (Actual)
January 9, 2024
Study Record Updates
Last Update Posted (Actual)
January 9, 2024
Last Update Submitted That Met QC Criteria
December 25, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 04-2023-200228
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Evaluation of Corneal Endothelium in Elderly Diabetic Patient
-
Healthpoint HospitalUnknownEvaluation of ASA Fasting Recommendations in Diabetic Patients
-
Assiut UniversityCompletedEvaluation Thyroid Functions in Diabetic PatientEgypt
-
National Taiwan University HospitalUnknownEvaluation of Cerebral Small Vessel Disease in Patient With Primary AldosteronismTaiwan
Clinical Trials on Non-contact specular microscopy
-
Assiut UniversityNot yet recruiting
-
Heba Allah Nashaat MohamedAssiut UniversityRecruitingKeratoconus, CollagenEgypt
-
Assiut UniversityUnknownAccelerated Corneal Collagen Cross Linking
-
Assiut UniversityNot yet recruitingCorneal Endothelial Cell Changes in Diabetic Patients
-
Assiut UniversityNot yet recruitingEndothelial Cell Loss, Corneal
-
Federal University of São PauloCompleted
-
Groupe Hospitalier Paris Saint JosephWithdrawn
-
Assiut UniversityCompleted
-
Ulucanlar Eye Training and Research HospitalCompletedAge Related Macular Degeneration